sciencedaily - A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach the brain without invasive surgery. When paired with dru…
AI Summary: A novel nasal‐delivered nanotherapy that triggers the STING immune pathway via gold‐core nanoparticles has been shown in mice to nearly wipe out aggressive brain tumors. This noninvasive approach offers hope for a radically new treatment modality in glioblastoma.
Therapeutic HPV vaccine slows throat tumors in preclinical tests / 3 months
Gene‑editing trials explore one‑time fix for high cholesterol / 3 months
Bayer’s Asundexian Reduces Stroke Risk by 26% in Phase 3 Trial / 3 months
Eikon Therapeutics raises $381M IPO for cancer drug advancement / 3 months
Aktis Oncology IPO boosts radiopharmaceutical pipeline / 4 months
Tumor bacteria drive head and neck immunotherapy resistance / 4 months
Giredestrant lowers recurrence risk in early-stage breast cancer / 5 months
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.